Table 3. Sensitivity analyses of country-specific estimates and pooled estimates of historical smallpox vaccine effectiveness against mpox in Denmark, the Netherlands, France and Spain, March–July 2022.
Country | Denmark | France | The Netherlands | Spain |
---|---|---|---|---|
Total number of cases | 5 | 140 | 113 | 258 |
Cases with known vaccination status | 5 | 74 | 97 | 131 |
Proportion of the population vaccinated | 95% | 90% | 89% | 90% |
Missing values as non-vaccinated | ||||
Proportion of cases vaccinated | 100% | 39% | 71% | 30% |
VE (95% CI) | NA (NA–100) | 93% (90–95) | 70% (54–80) | 95% (94–96) |
Pooled VE | 90% (58–98) | |||
Missing values as vaccinated | ||||
Proportion of cases vaccinated | 100% | 86% | 85% | 79% |
VE (95% CI) | NA (NA–100) | 33% (-10 to 57) | 30% (-21 to 57) | 57% (42–68) |
Pooled VE | 46% (18–65) |
CI: confidence interval; NA: not ascertainable; VE: vaccine effectiveness.